Cargando…
The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction
BACKGROUND: Chronic total occlusion (CTO) is an angiographic picture of total occlusion without blood flow which is estimated to have lasted at least 3 months. This study attempted to provide an overview of the levels of matrix metalloproteinase-9 (MMP-9), soluble suppression tumorigenicity 2 (sST2)...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990544/ https://www.ncbi.nlm.nih.gov/pubmed/36896223 http://dx.doi.org/10.14740/cr1455 |
_version_ | 1784901955235086336 |
---|---|
author | Artha, I. Made Junior Rina Bakta, I. Made Manuaba, Ida Bagus Putra Wita, I. Wayan Rohman, Mohammad Saifur Astawa, I. Nyoman Mantik Bhargah, Agha |
author_facet | Artha, I. Made Junior Rina Bakta, I. Made Manuaba, Ida Bagus Putra Wita, I. Wayan Rohman, Mohammad Saifur Astawa, I. Nyoman Mantik Bhargah, Agha |
author_sort | Artha, I. Made Junior Rina |
collection | PubMed |
description | BACKGROUND: Chronic total occlusion (CTO) is an angiographic picture of total occlusion without blood flow which is estimated to have lasted at least 3 months. This study attempted to provide an overview of the levels of matrix metalloproteinase-9 (MMP-9), soluble suppression tumorigenicity 2 (sST2), and N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) as remodeling, inflammatory, and atherosclerotic markers, as well as changes in the angina severity in patients with CTO who underwent percutaneous coronary intervention (PCI) compared to those without PCI. METHODS: This study is a preliminary report with quasi-experimental design study with a pre-test and post-test approach to compare PCI’s effect in CTO patients towards changes in MMP-9, sST2, NT-pro-BNP levels, and changes in the angina severity. Twenty subjects underwent PCI and 20 subjects with optimal medical therapy, who were then assessed at baseline and 8 weeks after intervention. RESULTS: The results of this preliminary report showed that decreased MMP-9 (pre-test: 12.07 ± 1.27 ng/mL vs. post-test: 9.91 ± 5.19 ng/mL, P = 0.049), sST2 (pre-test: 37.65 ± 20.00 ng/mL vs. post-test: 29.74 ± 15.17 ng/mL, P = 0.026) and NT-pro-BNP (pre-test: 0.63 ± 0.23 ng/mL vs. post-test: 0.24 ± 0.10 ng/mL, P < 0.001) levels were found after 8 weeks of PCI compared to those without such intervention. The levels of NT-pro-BNP were lower in the PCI group (0.24 ± 0.10 ng/mL) than in the non-PCI group (0.56 ± 0.23 ng/mL; P < 0.001). Moreover, there was an improvement of angina severity in PCI group than without PCI (P < 0.039). CONCLUSIONS: Although this preliminary report found a significant decrease in MMP-9, NT-pro-BNP, and sST2 levels in CTO patients who had undergone PCI compared to those without PCI, as well as improved angina severity in these patients, this study still has limitations. The number of samples was so small that similar studies with larger sample sizes or multicenter investigations are required to deliver more trustworthy and useful results. Nevertheless, we encourage this study as a preliminary baseline for further studies in the future. |
format | Online Article Text |
id | pubmed-9990544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elmer Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-99905442023-03-08 The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction Artha, I. Made Junior Rina Bakta, I. Made Manuaba, Ida Bagus Putra Wita, I. Wayan Rohman, Mohammad Saifur Astawa, I. Nyoman Mantik Bhargah, Agha Cardiol Res Short Communication BACKGROUND: Chronic total occlusion (CTO) is an angiographic picture of total occlusion without blood flow which is estimated to have lasted at least 3 months. This study attempted to provide an overview of the levels of matrix metalloproteinase-9 (MMP-9), soluble suppression tumorigenicity 2 (sST2), and N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) as remodeling, inflammatory, and atherosclerotic markers, as well as changes in the angina severity in patients with CTO who underwent percutaneous coronary intervention (PCI) compared to those without PCI. METHODS: This study is a preliminary report with quasi-experimental design study with a pre-test and post-test approach to compare PCI’s effect in CTO patients towards changes in MMP-9, sST2, NT-pro-BNP levels, and changes in the angina severity. Twenty subjects underwent PCI and 20 subjects with optimal medical therapy, who were then assessed at baseline and 8 weeks after intervention. RESULTS: The results of this preliminary report showed that decreased MMP-9 (pre-test: 12.07 ± 1.27 ng/mL vs. post-test: 9.91 ± 5.19 ng/mL, P = 0.049), sST2 (pre-test: 37.65 ± 20.00 ng/mL vs. post-test: 29.74 ± 15.17 ng/mL, P = 0.026) and NT-pro-BNP (pre-test: 0.63 ± 0.23 ng/mL vs. post-test: 0.24 ± 0.10 ng/mL, P < 0.001) levels were found after 8 weeks of PCI compared to those without such intervention. The levels of NT-pro-BNP were lower in the PCI group (0.24 ± 0.10 ng/mL) than in the non-PCI group (0.56 ± 0.23 ng/mL; P < 0.001). Moreover, there was an improvement of angina severity in PCI group than without PCI (P < 0.039). CONCLUSIONS: Although this preliminary report found a significant decrease in MMP-9, NT-pro-BNP, and sST2 levels in CTO patients who had undergone PCI compared to those without PCI, as well as improved angina severity in these patients, this study still has limitations. The number of samples was so small that similar studies with larger sample sizes or multicenter investigations are required to deliver more trustworthy and useful results. Nevertheless, we encourage this study as a preliminary baseline for further studies in the future. Elmer Press 2023-02 2023-02-25 /pmc/articles/PMC9990544/ /pubmed/36896223 http://dx.doi.org/10.14740/cr1455 Text en Copyright 2023, Artha et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Communication Artha, I. Made Junior Rina Bakta, I. Made Manuaba, Ida Bagus Putra Wita, I. Wayan Rohman, Mohammad Saifur Astawa, I. Nyoman Mantik Bhargah, Agha The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction |
title | The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction |
title_full | The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction |
title_fullStr | The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction |
title_full_unstemmed | The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction |
title_short | The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction |
title_sort | effects of percutaneous coronary intervention on biomarkers and quality of life in patients with chronic total coronary artery obstruction |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990544/ https://www.ncbi.nlm.nih.gov/pubmed/36896223 http://dx.doi.org/10.14740/cr1455 |
work_keys_str_mv | AT arthaimadejuniorrina theeffectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction AT baktaimade theeffectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction AT manuabaidabagusputra theeffectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction AT witaiwayan theeffectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction AT rohmanmohammadsaifur theeffectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction AT astawainyomanmantik theeffectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction AT bhargahagha theeffectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction AT arthaimadejuniorrina effectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction AT baktaimade effectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction AT manuabaidabagusputra effectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction AT witaiwayan effectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction AT rohmanmohammadsaifur effectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction AT astawainyomanmantik effectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction AT bhargahagha effectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction |